Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about PHRRF

Recent news which mentions PHRRF

PharmaTher Is 'One Step Closer To Being A Ketamine Leader' Due To FDA Acceptance
Tickers PHRRF
Tags Ketamine Treatment Health Care Psychedelics
From Benzinga
NY Consulting Firm Predicts Psychedelic Drugs Market Will Generate Over $12B In Next 12 Years
Tickers ATAI CMPS CYBN JAZZ
Tags Psychedelics Small Cap Research Nester
From Benzinga
Psyched: Psilocybin Therapy For Depression, UK Rescheduling, US Policy Reform And More
Tickers ATAI AWKNF CMND CMPS
Tags Cannabis PSIL PHRRF
From Benzinga
PharmaTher Aims To Mitigate Ketamine Shortage With New FDA Application
Tickers PHRRF
Tags News Abbreviated New Drug Application Markets
From Benzinga
Psyched: Germany Ships LSD Prodrugs Via DHL, Minneapolis Decriminalizes, Wiz Khalifa's Magic Pitch & More
Tickers CLABF CMPS ENVB FLHLF
Tags Top Stories ENVB CLABF
From Benzinga
PharmaTher's DMT Patch Shows Positive Outcomes, Investment Toward The Clinical Stage
Tickers PHRRF
Tags Markets Terasaki Institute Sairiyo Therapeutics Inc
From Benzinga
Psyched: A $100M Donation Pledge, Frank Biden Gets Candid, New Search Trends & More
Tickers BETRF CYBN DMTTF DSNKY
Tags FDA Psychedelics Financing Asset Sales
From Benzinga
BetterLife Fast Tracks Its US Patent For Non-Hallucinogenic Compound And Other LSD Derivatives
Tickers BETRF PHRRF
Tags Next/Generation Psychedelics Psychedelics Psychedelic/Assisted Therapies
From Benzinga
Ketamine News: PharmaTher Begins FDA Filing For KETARX Application, Stella Acquires Field Trip Assets
Tickers FTHWF PHRRF
Tags PHRRF Market News Asset Sales
From Benzinga
PharmaTher's Novel Ketamine Heads For The US Market With New Collaboration Agreement
Tickers PHRRF
Tags Psychedelics Cannabis Ketamine Therapy
From Benzinga
Psyched: Psychedelics Reimbursement, Amanita Muscaria Boom, $53M Material Breach Lawsuit & More
Tickers CMND CMPS HUGE IWINF
Tags IXHL News HUGE
From Benzinga
Parkinson's Patients May Benefit From Ketamine, PharmaTher Applies For FDA Fast Track
Tickers PHRRF
Tags Parkinson's Disease PharmaTer Biotech
From Benzinga
Psyched: Canada's Case For Psilocybin Access And Microdose Trial, US Reform Update, Battle With DEA & More
Tickers IGXT NUMIF PHRRF RVVTF
Tags Penny Stocks Psilocybin program Benzinga
From Benzinga
MDMA Transdermal Patch Moves Toward First-In-Human Trials: Latest Development Update
Tickers PHRRF RVVTF
Tags News RVVTF Markets
From Benzinga
Ketamine Company Advances Parkinson's Treatment Through Final Stages Toward FDA Approval
Tickers PHRRF
Tags Penny Stocks Benzinga FDA
From Benzinga
Psyched: Hawaii And Minnesota's Bills, Studying 2C-B Vs. Psilocybin, Filament CEO, Plus Brock Pierce And Jeremy Gardner Discuss The Industry's Future And More
Tickers AGNPF AWKNF CMND CYBN
Tags FLHLF LMLLF Legal
From Benzinga
Development Of DMT Transdermal Patch With Eye Disease Treatment In Mind
Tickers LMLLF PHRRF
Tags Psychedelics DMT Entities Drug Delivery Technologies
From Benzinga
Psyched: 12 States Discuss Legalization Bills, Ceremonies For Veterans With TBI, Ketamine And MDMA Fast-Tracks & More
Tickers AWKNF NUMIF OPTHF PHRRF
Tags News SEEL Management
From Benzinga
PharmaTher Seeks Regulatory Approval Of New Ketamine Delivery System For Anesthesia And Sedation
Tickers PHRRF
Tags Ketamine Markets Guidance
From Benzinga
Psyched: Australia Legalizes Psychedelics Therapy, BC's Decrim, State Bills, Millions For Trials & Clinics
Tickers IWINF ORIG PHRRF PSIL
Tags Psilocybin/Assisted Therapy News ORIG
From Benzinga
MDMA News: Optimi's New Drug Now Available, Revive Advances Transdermal Patch Evaluations
Tickers OPTHF PHRRF RVVTF
Tags News RVVTF Markets
From Benzinga
PharmaTher Holdings Nabs New Orphan Drug Status, Discusses Further Fast-Track, Partners For MDMA Patch
Tickers PHRRF RVVTF
Tags News MDMA Therapy FDA Approval
From Benzinga
Psyched: States With Psychedelics Legalization Bills, Next-Gen Molecule For Addiction Treatment And More
Tickers CLABF CMND CYBN FLHLF
Tags FLHLF TRUFF CLABF
From Benzinga
Search Is On For Psychedelic Patents & FDA Designations, 3 Companies Share News
Tickers MSSTF PHRRF
Tags Orphan Drug Designation United States Patent and Trademark Office (USPTO) Ketamine
From Benzinga
Psychedelics Market Could Reach $12B By 2029, Says New Report
Tickers CMPS PHRRF
Tags PHRRF Global Psychedelics Therapeutic Market Market News
From Benzinga
2 Psychedelics Companies Tout Advanced Clinical Trials, Progress With Key Products
Tickers GHRS PHRRF
Tags Management News Guidance
From Benzinga
FDA OKs Ketamine For Treating Organ Transplant Injuries With 'Orphan Drug' Status
Tickers PHRRF
Tags Orphan Drug Designation Markets Legal
From Benzinga
Ketamine Could Soon Be A Treatment Option For This Rare Genetic Neurological Disorder
Tickers PHRRF
Tags Benzinga Penny Stocks Cannabis
From Benzinga
Ketamine for Parkinson's Disease, PharmaTher Holdings Announces Grant of U.S. Patent To Cover It
Tickers PHRRF
Tags Penny Stocks Benzinga FDA
From Benzinga
PharmaTher Provides Business Highlights And Releases Audited Annual Financials
Tickers PHRRF
Tags News Earnings Markets
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.